當升科技(300073.SZ):擬與蜀道新材料共同成立當升蜀道(攀枝花)新材料
格隆匯1月13日丨當升科技(300073.SZ)公佈,為進一步加快公司磷酸(錳)鐵鋰產能建設,推動當升科技(攀枝花)新材料產業基地首期項目的投資與運營,北京當升材料科技股份有限公司與四川蜀道新材料科技集團股份有限公司(下稱“蜀道新材料”)於2023年1月13日分別在北京市和成都市以視頻的方式簽訂了《攀枝花磷酸(錳)鐵鋰項目合資協議》,雙方共同出資在攀枝花市成立當升蜀道(攀枝花)新材料有限公司(最終以工商登記註冊為準),主要負責當升科技(攀枝花)新材料產業基地首期項目建設、生產及運營管理等相關業務。合資公司註冊資本為人民幣10億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.